Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

MPAY vs. MSOS: which is better?

Bottom line

MPAY vs MSOS: the short answer

MPAY (Akros Monthly Payout ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.

Updated Nov 19, 2026

MPAY vs MSOS side by side

MPAYMSOS
TypeETFETF
Fund familyInnovatorAdvisorshares
CategoryOtherOther
Expense ratio—0.78%
Annual cost per $10k—$78
10-yr cost on $10k (prospectus)—$927
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+23.4%
5-yr return (annualized)—−33.6%
10-yr return (annualized)——
Best quarter—+102.2%
Worst quarter—−50.4%
Net assets (fund)—$1.0B
Number of holdings—61
Portfolio turnover—5%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

MPAY and MSOS share none of their top holdings.

MPAY top 10

    MSOS top 10

    1. Curaleaf Holdings Inc — 12.32%
    2. Trulieve Cannabis Corp — 9.56%
    3. Blackrock Treasury Trust — 5.78%
    4. Terrascend Corp — 2.70%
    5. Marex Capital Markets Inc. — 2.16%
    6. Cantor Fitzgerald & Co. — 1.08%
    7. Morgan Stanley & Co. Llc — 0.94%
    8. Glass House Brands Inc — 0.93%
    9. Nomura Securities International, Inc. — 0.85%
    10. Cantor Fitzgerald & Co. — 0.78%

    FAQ

    What is the difference between MPAY and MSOS?
    MPAY (Akros Monthly Payout ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.
    Should I own both MPAY and MSOS?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.